Lars Wortmann

1.5k total citations
18 papers, 692 citations indexed

About

Lars Wortmann is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Lars Wortmann has authored 18 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Lars Wortmann's work include Ubiquitin and proteasome pathways (3 papers), Catalytic C–H Functionalization Methods (2 papers) and Chemical Synthesis and Analysis (2 papers). Lars Wortmann is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Catalytic C–H Functionalization Methods (2 papers) and Chemical Synthesis and Analysis (2 papers). Lars Wortmann collaborates with scholars based in Germany, United Kingdom and South Sudan. Lars Wortmann's co-authors include Dieter Enders, René Peters, Michael Brands, Dominik Mumberg, Philipp M. Cromm, Katrin Juenemann, Laura M. Luh, U. Scheib, Gerhard Siemeister and Uwe Eberspächer and has published in prestigious journals such as Angewandte Chemie International Edition, Accounts of Chemical Research and Molecular Cell.

In The Last Decade

Lars Wortmann

17 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Wortmann Germany 11 476 232 172 159 40 18 692
Sylvia Musto United States 18 466 1.0× 328 1.4× 216 1.3× 160 1.0× 36 0.9× 32 943
Ferdinando Maria Milazzo Italy 15 448 0.9× 163 0.7× 218 1.3× 199 1.3× 38 0.9× 30 692
Kimberly Gray United States 13 478 1.0× 255 1.1× 108 0.6× 167 1.1× 39 1.0× 17 683
Gunther Zimmermann Germany 10 942 2.0× 235 1.0× 218 1.3× 114 0.7× 62 1.6× 15 1.1k
Renaud Prudent France 18 687 1.4× 188 0.8× 186 1.1× 108 0.7× 45 1.1× 37 1.1k
Xingzhi Tan United States 13 486 1.0× 363 1.6× 113 0.7× 130 0.8× 100 2.5× 20 815
Eliud Hernandez O'Farril Puerto Rico 15 412 0.9× 124 0.5× 246 1.4× 158 1.0× 62 1.6× 31 755
David A. Janowick United States 11 539 1.1× 209 0.9× 126 0.7× 326 2.1× 35 0.9× 14 814
Susan E. Kephart United States 9 317 0.7× 142 0.6× 193 1.1× 49 0.3× 50 1.3× 14 571
Andrew M. Creighton United Kingdom 12 507 1.1× 230 1.0× 100 0.6× 99 0.6× 22 0.6× 15 683

Countries citing papers authored by Lars Wortmann

Since Specialization
Citations

This map shows the geographic impact of Lars Wortmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Wortmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Wortmann more than expected).

Fields of papers citing papers by Lars Wortmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Wortmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Wortmann. The network helps show where Lars Wortmann may publish in the future.

Co-authorship network of co-authors of Lars Wortmann

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Wortmann. A scholar is included among the top collaborators of Lars Wortmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Wortmann. Lars Wortmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cossa, Giacomo, Florian Prinz, Apoorva Baluapuri, et al.. (2021). Localized inhibition of protein phosphatase 1 by NUAK1 promotes spliceosome activity and reveals a MYC-sensitive feedback control of transcription. Molecular Cell. 81(11). 2495–2495. 4 indexed citations
2.
Luh, Laura M., U. Scheib, Katrin Juenemann, et al.. (2020). Beute für das Proteasom: Gezielter Proteinabbau aus medizinalchemischer Perspektive. Angewandte Chemie. 132(36). 15576–15595. 6 indexed citations
3.
Luh, Laura M., U. Scheib, Katrin Juenemann, et al.. (2020). Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective. Angewandte Chemie International Edition. 59(36). 15448–15466. 133 indexed citations
4.
Cossa, Giacomo, Florian Prinz, Apoorva Baluapuri, et al.. (2020). Localized Inhibition of Protein Phosphatase 1 by NUAK1 Promotes Spliceosome Activity and Reveals a MYC-Sensitive Feedback Control of Transcription. Molecular Cell. 77(6). 1322–1339.e11. 40 indexed citations
5.
Wortmann, Lars, B. Lindenthal, Peter Muhn, et al.. (2019). Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo. Journal of Medicinal Chemistry. 62(22). 10321–10341. 12 indexed citations
6.
Wengner, Antje M., Gerhard Siemeister, Ulrich Lücking, et al.. (2019). The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models. Molecular Cancer Therapeutics. 19(1). 26–38. 145 indexed citations
7.
Lemos, Clara, Duy Nguyen, Lars Wortmann, et al.. (2018). Abstract 5866: Discovery and profiling of a highly potent and selective ERK5 inhibitor: BAY-885. Cancer Research. 78(13_Supplement). 5866–5866. 1 indexed citations
8.
Hog, Daniel T., Alexander Sudau, Daniel Rackl, et al.. (2018). Late-Stage Sulfoximidation of Electron-Rich Arenes by Photoredox Catalysis. Synlett. 29(20). 2679–2684. 17 indexed citations
9.
10.
Sautier, Brice, Carl F. Nising, & Lars Wortmann. (2016). Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective. Angewandte Chemie International Edition. 55(52). 15982–15988. 13 indexed citations
11.
Galloway, Warren R. J. D., et al.. (2013). Mild and Efficient Synthesis of Benzo-Fused Seven- and Eight-membered Ring Lactams: A Convenient Approach to Biologically Interesting Chemotypes. Synthetic Communications. 43(11). 1508–1516. 12 indexed citations
12.
Galloway, Warren R. J. D., Albert Isidro‐Llobet, James T. Hodgkinson, et al.. (2011). Novel and Efficient Copper‐Catalysed Synthesis of Nitrogen‐Linked Medium‐Ring Biaryls. Chemistry - A European Journal. 17(10). 2981–2986. 17 indexed citations
13.
Santamaría, Anna, Rüdiger Neef, Uwe Eberspächer, et al.. (2007). Use of the Novel Plk1 Inhibitor ZK-Thiazolidinone to Elucidate Functions of Plk1 in Early and Late Stages of Mitosis. Molecular Biology of the Cell. 18(10). 4024–4036. 161 indexed citations
14.
Enders, Dieter, et al.. (2004). A Highly Flexible Route to 1,2,3,4,5,6- Hexahydro-5-hydroxypyrimidin-2-ones as Potential HIV Protease Inhibitors. Heterocycles. 62(1). 559–559. 2 indexed citations
15.
Enders, Dieter & Lars Wortmann. (2002). Asymmetric Synthesis of 4,6-Disubstituted 1,2,3,4,5,6-Hexahydro-5-hydroxypyrimidin-2-ones as Potential HIV-Protease-Inhibitors. Heterocycles. 58(1). 293–293. 4 indexed citations
16.
Enders, Dieter, Lars Wortmann, & René Peters. (2000). Recovery of Carbonyl Compounds from N,N-Dialkylhydrazones. Accounts of Chemical Research. 33(3). 157–169. 105 indexed citations
17.
Enders, Dieter, et al.. (1999). Asymmetric Synthesis of 1,2,3,4,5,6-Hexahydro-5-hydroxypyrimidin-2-ones as Potential HIV-Protease Inhibitors. Helvetica Chimica Acta. 82(8). 1195–1201. 8 indexed citations
18.
Enders, Dieter, et al.. (1997). 2,2-dimethyl-1,3-dioxan-5-one. A dihydroxyacetone equivalent for asymmetric synthesis. RWTH Publications (RWTH Aachen).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvia Musto Breakdown of academic impact, for papers by Ferdinando Maria Milazzo Breakdown of academic impact, for papers by Kimberly Gray Breakdown of academic impact, for papers by Gunther Zimmermann Breakdown of academic impact, for papers by Renaud Prudent Breakdown of academic impact, for papers by Xingzhi Tan Breakdown of academic impact, for papers by Eliud Hernandez O'Farril Breakdown of academic impact, for papers by David A. Janowick Breakdown of academic impact, for papers by Susan E. Kephart Breakdown of academic impact, for papers by Andrew M. Creighton
Rankless by CCL
2026